Comparative performance of the protocol of plasma rich in growth factors - universal 1 (PRGF-U1) for obtaining platelet rich plasma
Aguirre, Augusto; Arbildo, Heber; Peralta, Javier.
J. oral res. (Impresa)
; 6(1): 16-18, Jan. 2017. tab
Artículo en Inglés | LILACS | ID: biblio-907700
Documentos relacionados
Platelet-Rich Plasma - a remedy present in every human being. History, functioning, and the benefits of therapy using it.
Recent Achievements in the Development of Biomaterials Improved with Platelet Concentrates for Soft and Hard Tissue Engineering Applications.
Standardization of a Protocol for Obtaining Platelet Rich Plasma from blood Donors; a Tool for Tissue Regeneration Procedures.
A retrospective analysis of a commercially available platelet-rich plasma kit during clinical use.
Action of Platelet-Rich Plasma on In Vitro Cellular Bioactivity: More than Platelets.
Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review.
Pure Platelet and Leukocyte-Platelet-Rich Plasma for Regenerative Medicine in Orthopedics-Time- and Preparation-Dependent Release of Growth Factors and Effects on Synovial Fibroblasts: A Comparative Analysis.
Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine.
Regenerative medicine: characterization of human bone matrix gelatin (BMG) and folded platelet-rich fibrin (F-PRF) membranes alone and in combination (sticky bone).
Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations.